UK markets closed

Oxford BioMedica plc (OXB.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
422.50-5.50 (-1.29%)
At close: 05:08PM GMT
Currency in GBp

Valuation measures4

Market cap (intra-day) 418.75M
Enterprise value 407.74M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.33
Price/book (mrq)1.89
Enterprise value/revenue 3.25
Enterprise value/EBITDA -842.43

Trading information

Stock price history

Beta (5Y monthly) 1.03
52-week change 3-47.03%
S&P500 52-week change 3-8.38%
52-week high 3918.00
52-week low 3276.62
50-day moving average 3412.41
200-day moving average 3433.30

Share statistics

Avg vol (3-month) 3132.67k
Avg vol (10-day) 386.05k
Shares outstanding 596.26M
Implied shares outstanding 6N/A
Float 869.22M
% held by insiders 16.19%
% held by institutions 162.88%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 330 May 2018

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022


Profit margin -19.54%
Operating margin (ttm)-10.15%

Management effectiveness

Return on assets (ttm)-2.40%
Return on equity (ttm)-13.60%

Income statement

Revenue (ttm)125.57M
Revenue per share (ttm)1.41
Quarterly revenue growth (yoy)-21.20%
Gross profit (ttm)82.64M
Net income avi to common (ttm)-24.54M
Diluted EPS (ttm)0.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)118.55M
Total cash per share (mrq)1.23
Total debt (mrq)107.5M
Total debt/equity (mrq)41.34
Current ratio (mrq)1.83
Book value per share (mrq)2.31

Cash flow statement

Operating cash flow (ttm)-21.25M
Levered free cash flow (ttm)-27.38M